SignalXSignalX

PTGX Protagonist Therapeutics, Inc

8-K Current Report
Filed: February 25, 2026
Health Care
Pharmaceutical Preparations
Protagonist Therapeutics, Inc Overview

Protagonist Therapeutics, Inc (PTGX) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 and full year 2025 earnings reported February 25, 2026
  • • Full results and financial details contained in the furnished press release exhibit — key figures not disclosed in this item text
+1 more insights

Get deeper insights on Protagonist Therapeutics, Inc

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.